{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:10:51Z","timestamp":1790471451904,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Society of Nephrology Research Fellowship","award":["2012D000333"],"award-info":[{"award-number":["2012D000333"]}]},{"name":"Merck & Co. IDNT"},{"name":"Bristol Myer Squibb Institute for Medical Research"},{"name":"Sanofi-Synthelabo"},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1053\/j.ajkd.2014.06.008","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T23:45:22Z","timestamp":1406159122000},"page":"714-722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Visit-to-Visit Variability in Blood Pressure and Kidney and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Nephropathy: A Post Hoc Analysis From the RENAAL Study and the Irbesartan Diabetic Nephropathy Trial"],"prefix":"10.1053","volume":"64","author":[{"given":"Ciaran J.","family":"McMullan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J.","family":"Lambers Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Henrik","family":"Parving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie P.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"de Zeeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9718","key":"10.1053\/j.ajkd.2014.06.008_bib1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","article-title":"Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ajkd.2014.06.008_bib2","doi-asserted-by":"crossref","first-page":"U160","DOI":"10.1161\/HYPERTENSIONAHA.110.162255","article-title":"The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population findings from NHANES III, 1988 to 1994","volume":"57","author":"Muntner","year":"2011","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ajkd.2014.06.008_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/HYPERTENSIONAHA.112.193094","article-title":"Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative","volume":"60","author":"Shimbo","year":"2012","journal-title":"Hypertension"},{"issue":"11","key":"10.1053\/j.ajkd.2014.06.008_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2014.06.008_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2215\/CJN.10131012","article-title":"Association of BP variability with mortality among African Americans with CKD","volume":"8","author":"McMullan","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2014.06.008_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2011.10.033","article-title":"Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes","volume":"220","author":"Okada","year":"2012","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1053\/j.ajkd.2014.06.008_bib7","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1093\/ndt\/gfs328","article-title":"Blood pressure variability and outcomes in chronic kidney disease","volume":"27","author":"Di Iorio","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2014.06.008_bib8","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/dc10-1000","article-title":"The role of blood pressure variability in the development of nephropathy in type 1 diabetes","volume":"33","author":"Kilpatrick","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1053\/j.ajkd.2014.06.008_bib9","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.2337\/dc12-2087","article-title":"Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes","volume":"36","author":"Okada","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1053\/j.ajkd.2014.06.008_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2362.2011.02574.x","article-title":"Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5\u20225-year prospective analysis","volume":"42","author":"Hsieh","year":"2012","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2014.06.008_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ki.2013.132","article-title":"Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease","volume":"84","author":"Mallamaci","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2014.06.008_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/hr.2012.145","article-title":"Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease","volume":"36","author":"Yokota","year":"2013","journal-title":"Hypertens Res"},{"issue":"5","key":"10.1053\/j.ajkd.2014.06.008_bib13","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/ki.1997.463","article-title":"Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients","volume":"52","author":"Christensen","year":"1997","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2014.06.008_bib14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2014.06.008_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.ajkd.2014.06.008_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3317\/jraas.2000.062","article-title":"The losartan renal protection study\u2014rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM With the Angiotensin II Antagonist Losartan)","volume":"1","author":"Brenner","year":"2000","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"issue":"4","key":"10.1053\/j.ajkd.2014.06.008_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ndt\/15.4.487","article-title":"The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics. For the Collaborative Study Group","volume":"15","author":"Rodby","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2014.06.008_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ajkd.2011.09.017","article-title":"Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database","volume":"59","author":"Packham","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2014.06.008_bib19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2014.06.008_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2014.06.008_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2014.06.008_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","article-title":"Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke","volume":"9","author":"Rothwell","year":"2010","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1053\/j.ajkd.2014.06.008_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/hr.2011.170","article-title":"The impact of visit-to-visit variability in blood pressure on renal function","volume":"35","author":"Kawai","year":"2012","journal-title":"Hypertens Res"},{"issue":"11","key":"10.1053\/j.ajkd.2014.06.008_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/jhh.2013.33","article-title":"Visit-to-visit and 24-h blood pressure variability: association with endothelial and smooth muscle function in African Americans","volume":"27","author":"Diaz","year":"2013","journal-title":"J\u00a0Hum Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2014.06.008_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/hr.2011.135","article-title":"Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans","volume":"35","author":"Diaz","year":"2012","journal-title":"Hypertens Res"},{"issue":"3","key":"10.1053\/j.ajkd.2014.06.008_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jash.2011.03.001","article-title":"Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease","volume":"5","author":"Nagai","year":"2011","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"7","key":"10.1053\/j.ajkd.2014.06.008_bib27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ajh\/hpt040","article-title":"Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"26","author":"Shimbo","year":"2013","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1053\/j.ajkd.2014.06.008_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/10641963.2012.712180","article-title":"Labile hypertension: characteristics of a referred cohort","volume":"35","author":"Elliott","year":"2013","journal-title":"Clin Exp Hypertens"},{"issue":"3","key":"10.1053\/j.ajkd.2014.06.008_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11906-011-0201-3","article-title":"Does blood pressure variability modulate cardiovascular risk?","volume":"13","author":"Rothwell","year":"2011","journal-title":"Curr Hypertens Rep"},{"issue":"14","key":"10.1053\/j.ajkd.2014.06.008_bib30","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/archinte.162.14.1636","article-title":"Successful blood\u00a0pressure control in the African American Study of Kidney Disease and Hypertension","volume":"162","author":"Wright","year":"2002","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1053\/j.ajkd.2014.06.008_bib31","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/ndt\/13.10.2547","article-title":"Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group","volume":"13","author":"Schwartz","year":"1998","journal-title":"Nephrol Dial Transplant"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614009093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614009093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:28:49Z","timestamp":1759458529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638614009093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0272638614009093"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.06.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718509953.793498052","asserted-by":"object"}]},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visit-to-Visit Variability in Blood Pressure and Kidney and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Nephropathy: A Post Hoc Analysis From the RENAAL Study and the Irbesartan Diabetic Nephropathy Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}